EDITAS MEDICINE, INC. ADVISORY SERVICE AGREEMENTAdvisory Services Agreement • August 7th, 2020 • Editas Medicine, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Advisory Services Agreement (the “Agreement”), is signed concurrently with the Separation Agreement dated May 1, 2020, to which this Agreement is attached as Exhibit A (the “Separation Agreement”) and effective as of May 4, 2020 (the “Effective Date”) is entered into by Editas Medicine, Inc., a Delaware corporation (the “Company”), and Judith R. Abrams, M.D., having an address set forth under his or her signature hereto (the “Advisor”).
VIA EMAIL April 30, 2020 Judith R. Abrams Montclair, NJ 07042 abramsjr@earthlink.net Dear Judith:Severance Agreement • August 7th, 2020 • Editas Medicine, Inc. • Biological products, (no disgnostic substances) • Massachusetts
As we discussed, your employment with Editas Medicine, Inc. (the “Company”) will end effective May 1, 2020 (the “Separation Date”). As we also discussed, you will be eligible to receive the Benefits described in paragraph 2 below if you sign and return this letter agreement to me by May 22, 2020 and do not revoke your agreement (as described below). By signing and returning this letter agreement and not revoking your acceptance, you will be entering into a binding agreement with the Company and will be agreeing to the terms and conditions set forth in the numbered paragraphs below, including the release of claims set forth in paragraph 3. Therefore, you are advised to consult with an attorney before signing this letter agreement and you have been given at least twenty-one (21) days to do so. If you sign this letter agreement, you may change your mind and revoke your agreement during the seven (7) business day period after you have signed it (the “Revocation Period”) by notifying me in
